Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 050646

Expand all

CEPTAZ (CEFTAZIDIME)
500MG/VIAL
Marketing Status: Discontinued

Active Ingredient: CEFTAZIDIME
Proprietary Name: CEPTAZ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 500MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050646
Product Number: 001
Approval Date: Sep 27, 1990
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Discontinued
Patent and Exclusivity Information

CEPTAZ (CEFTAZIDIME)
1GM/VIAL
Marketing Status: Discontinued

Active Ingredient: CEFTAZIDIME
Proprietary Name: CEPTAZ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1GM/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050646
Product Number: 002
Approval Date: Sep 27, 1990
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Discontinued
Patent and Exclusivity Information

CEPTAZ (CEFTAZIDIME)
2GM/VIAL
Marketing Status: Discontinued

Active Ingredient: CEFTAZIDIME
Proprietary Name: CEPTAZ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2GM/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050646
Product Number: 003
Approval Date: Sep 27, 1990
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Discontinued
Patent and Exclusivity Information

CEPTAZ (CEFTAZIDIME)
10GM/VIAL
Marketing Status: Discontinued

Active Ingredient: CEFTAZIDIME
Proprietary Name: CEPTAZ
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10GM/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N050646
Product Number: 004
Approval Date: Sep 27, 1990
Applicant Holder Full Name: GLAXOSMITHKLINE
Marketing Status:  Discontinued
Patent and Exclusivity Information